60: Improving Care and Raising Awareness for NMOSD

Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, we spoke with Friedmann Paul, MD, head, Clinical Neuroimmunology Research Group, NeuroCure Clinical Research Center, and head, Clinical and Experimental Neuroimmunology, Experimental and Clinical Research Center, Charité–Universitätsmedizin Berlin. He shared his perspective on the state of care in neuromyelitis optica spectrum disorder (NMOSD), the need to raise awareness for symptomatic care and patient challenges, and the potential of novel therapeutic approaches to improve care. Episode Breakdown: 2:00 – State of diagnosis and care for NMOSD and similar disorders 6:00 – Role of NMOSD Awareness Month and advocacy efforts 8:45 – Current challenges with symptomatic management 11:20 – Multidisciplinary communication, coordination, and collaboration 13:05 – Neurology News Minute 16:45 – The potential of self-tolerization and curing NMOSD 19:05 – Nonpharmacologic approaches to care 20:40 – The need to improve physician awareness and education 22:45 – Advice for communicating the diagnosis to patients 24:45 – The need for patient advocacy groups The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Donepezil Transdermal System Wins FDA Approval to Treat Alzheimer Disease Dementia Sarepta Details Phase 3 EMBARK Study in DMD Ganaxolone Wins Landmark Approval for CDKL5 Deficiency Disorder Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.